In contrast, SOX18 demonstrated reduced mRNA expression in LSCC and LUAD relative to NMLT (both p < 0.0001), while its protein levels were significantly elevated in both cancer types (p < 0.0001) (Figure 3C). Here, SOX18 is linked to cancer.